Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: COMTAN

« Back to Dashboard
Comtan is a drug marketed by Orion Pharma and is included in one NDA. It is available from ten suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has forty-four patent family members in thirty-seven countries.

The generic ingredient in COMTAN is entacapone. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the entacapone profile page.

Summary for Tradename: COMTAN

Suppliers: see list10

Pharmacology for Tradename: COMTAN

Clinical Trials for: COMTAN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma
TABLET;ORAL020796-001Oct 19, 1999RXYes6,599,530<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: COMTAN

Drugname Dosage Strength RLD Submissiondate
entacaponeTablets200 mgComtan4/11/2007

International Patent Family for Tradename: COMTAN

Country Document Number Publication Date
New Zealand510583Sep 27, 2002
Ukraine73925Sep 17, 2001
Norway20011278Mar 13, 2001
World Intellectual Property Organization (WIPO)0015196Mar 23, 2000
Portugal1112065Apr 30, 2004
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn